Antiviral properties of prodelphinidin B-2 3′-O-gallate from green tea leaf

Antiviral Chemistry and Chemotherapy

Volumn 13, Issue 4, 2002, Pages 223-229

  Cheng, Hua Yew ^a   Lin, Chun Ching ^a   Lin, Ta Chen ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b Ta Jen Institute of Technology   (Taiwan)

Author keywords

Anti HSV 2 activity; Late stage of viral infection; Prodelphinidin B 2 3 O gallate; Viral attachment; Viral penetration

Indexed keywords

GALLIC ACID DERIVATIVE; GREEN TEA EXTRACT; PROANTHOCYANIDIN DERIVATIVE; PRODELPHINIDIN B2 3' O GALLATE; UNCLASSIFIED DRUG; ANTHOCYANIN; ANTIVIRUS AGENT; PROANTHOCYANIDIN; PRODELPHINIDIN B 2 3' O GALLATE; PRODELPHINIDIN B-2 3'-O-GALLATE;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE COURSE; DRUG CYTOTOXICITY; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; IC 50; IN VITRO STUDY; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; TEA; VERO CELL; VIRUS ADSORPTION; VIRUS CULTURE; VIRUS INFECTIVITY; VIRUS INHIBITION; ANIMAL; CERCOPITHECUS; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; PHYSIOLOGY; TIME; VIROLOGY;

ANIMALS; ANTHOCYANINS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; DOSE-RESPONSE RELATIONSHIP, DRUG; HERPESVIRUS 2, HUMAN; INHIBITORY CONCENTRATION 50; PLANT LEAVES; PLAQUE ASSAY; PROANTHOCYANIDINS; TEA; TIME FACTORS; VERO CELLS;

EID: 0036654692     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020201300403     Document Type: Article

References (35)

1. Albin R, Chase R, Risano C, Lieberman M, Ferrari E, Skelton A, Buontempo P, Cox S, DeMartino J, Wright-Minogue J, Jirau-Lucca G, Kelly J, Afonso A, Kwong AD, Rozhon EJ & O'Connell JF (1997) SCH 43478 and analogs: in vitro activity and in vivo efficacy of novel agents for herpesvirus type 2. Antiviral Research 35:139-146.
2. Andersen DO, Weber ND, Wood SG, Hughtas BG, Murray BK & North JA (1991) In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives. Antivira Research 16:185-196.
3. Aoki H, Akaike T, Abe K, Kuroda M, Arai S, Okamura R, Negi A & Maeda H (1995) Antiviral effect of oryzacystatin, a proteinase inhibitor in rice, against herpes simplex virus type 1 in vitro and in vivo. Antimicrobial Agents and Chemotherapy 39:846-849.
4. Baringer RJ & Swoveland P (1973) Recovery of herpes-simplex virus from human trigeminal ganglions. New England Journal of Medicine 288:648-650.
5. Boulware SL, Bronstein JC, Nordby EC & Weber PC (2001) Identification and characterization of benzothiophene inhibitor of herpes simplex virus type 1 replication which acts at the immediate early stage of infection. Antiviral Research 51:111-125.
6. Bourne KZ, Bourne N, Reising SF & Stanberry LR (1999) Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2. Antiviral Research 42:219-226.
7. Carlucci MJ, Ciancia M, Matulewicz MC, Cerezo AS & Damonte EB (1999) Antiherpetic activity and mode of action of natural carrageenans of diverse structural types. Antiviral Research 43:93-102.
8. Cassady KA & Whitley RJ (1997) New therapeutic approaches to the alphaherpesvirus infections. Journal of Antimicrobial Chemotherapy 39:119-128.
9. Charlton JL (1998) Antiviral activity of lignans. Journal of Natural Products 61:1447-1451.
10. Coen DM (1994) Acyclovir-resistant, pathogenic herpesviruses. Trends in Microbiology 2:481-485.
11. De Bruyne T, Pieters L, Witvrouw M, De Clercq E, Vanden Berghe D & Vlietinck AJ (1999) Biological evaluation of proanthocyanidin dimmers and related polyphenols. Journal of Natural Products 62:954-958.
12. Felser J, Kichington PR, Inchauspe G, Straus SE & Ostrove JM (1988) Cell line containing varicella-zoster virus open reading frame 62 and expressing the 'IE' 175 protein complement ICP4 mutant of herpes simplex virus type 1. Journal of Virology 62:2076-2082.
13. Fukuchi K, Sagagami H, Okuda T, Hatano T, Tanumz S, Kitajima K, Inoue Y, Inoue S, Ichikawi S, Nonoyama M & Kono K (1989) Inhibition of herpes simplex infection by tannins and related compounds. Antiviral Research 11:285-298.
14. Gius D & Laimins LA (1989) Activation of human papillomavirus type 18 gene expression by herpes simplex virus type 1 viral transactivators and phorbol ester. Journal of Virology 63:555-563.
15. Haslam E (1996) Natural polyphenols (vegetable tannins) as drugs: possible modes of action. Journal of Natural Products 59:205-215.
16. Ikeda T, Ando J, Miyazono A, Zhu XH, Tsumagari H, Nohara T, Yokomizo K & Uyeda M (2000) Anti-herpes virus activity of Solanum steroidal glycosides. Biological and Pharmaceutical Bulletin 23:363-364.
17. Lin YM, Flavin MT, Schure R, Chen FC, Sidwell R, Barnard DL, Huffman JH & Kern ER (1999) Antiviral activities of biflavonoids. Planta Medica 65:120-125.
18. Logan WS, Tindall JP & Elson ML (1971) Chronic cutaneous herpes simplex. Archives of Dermatalogy 103:606-614.
19. Logu AD, Loy G, Pellerano ML, Bonsignore L & Schivo ML (2000) Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil. Antiviral Research 48:177-185.
20. Mann SL, Meyers JD, Holmes KL & Corey L (1984) Prevalence and incidence of herpes infections among homosexually active men. Journal of Infectious Disease 149:1026-1027.
21. Martin SF (1987) The amaryllidaceae alkaloids. The Alkaloids 30:251-253.
22. Nonaka G, Kawahara O & Nishioka I (1983) Taanins and related compounds. XV. A new class of dimeric flavan-3-ol gallates, Theasinensins A and B, and proanthocyanidin gallates from green tea leaf (1). Chemical and Pharmaceutical Bulletin 31:3906-3914.
23. Ostrove JM, Leonard J, Weck KE, Radson AB & Gendelman HE (1987) Activation of the human immunodeficiency virus by herpes simplex virus type 1. Journal of Virology 61:3726-3732.
24. Pass RF, Long WK, Whitley RJ, Soong SJ, Diethelm AG, Reynolds DW & Alford CA Jr (1978) Productive infection with cytomegalovirus and herpes simplex virus in renal transparent recipients: role of source kidney. Journal of Infectious Disease 137:556-563.
25. Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P, Desmyter J & De Clercq E (1988) Rapid and automated retrazolium-based colorimetric assay for the detection of anti-HIV compounds. Journal of Virological Methods 20:309-321.
26. Rajcani J & Vojvodova A (1998) The role of herpes simplex virus glycoproteins in the virus replication cycle. Acta Virologica 42:103-118.
27. Roizman B & Sears AE (1996) Herpes simplex virus and their replication. In Virology, vol. 2; pp. 2231-2295. Edited by BN Fileds, DM Knipe & PM Howley. Philadelphia: Lippincott-Raven Pulishers.
28. Rosenthal KS, Perez R & Hodnichak C (1985) Inhibition of herpes simplex virus type 2 penetration by cytochalasins B and D. Journal of General Virology 66:1601-1605.
29. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tiemey S, Nofziger TH, Currens MJ, Seniff D & Boyd MR (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Research 48:4827-4833.
30. Sindambiwe JB, Calomme M, Geerts S, Pieters L, Vlietinck AJ & Vanden Berghe DA (1998) Evaluation of biological activities of triterpenoid saponins from Maesa lanceolata. Journal of Natural Product 61:585-590.
31. Spear PG (1993) Entry of alphaherpesviruses into cells. Seminars in Virology 4:167-180.
32. Takechi M, Tanaka Y, Takehara M, Nonaka GI & Nishioka I (1985) Structure and antiherpetic activity among the tannins. Phytochemistry 24:2245-2250.
33. Tal-Singer R, Peng C, Ponce De Leon M, Abrams WR, Banfield BW, Tufaro F, Cohen GH & Eisenberg RJ (1995) Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. Journal of Virology 69:4471-4483.
34. Tsai Y, Cole LL, Davis LE, Lockwood SJ, Simmons V & Wild GC (1985) Antiviral properties of garlic: in vitro effects on influenza B, herpes simplex and coxsackie viruses. Planta Medica 5:460-461.
35. Weislow OS, Kiser R, Fine DL, Bader J, Shoemaker RH & Boyd MR (1989) New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. Journal of the National Cancer Institute 81:577-586.